Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

519 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.
Deeb KK, Trump DL, Johnson CS. Deeb KK, et al. Among authors: johnson cs. Nat Rev Cancer. 2007 Sep;7(9):684-700. doi: 10.1038/nrc2196. Nat Rev Cancer. 2007. PMID: 17721433 Review.
A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies.
Fountzilas C, Javle M, Tan W, Ma Y, Fetterly G, Iyer R, Johnson C. Fountzilas C, et al. Among authors: johnson c. Cancer. 2018 Oct 1;124(19):3890-3899. doi: 10.1002/cncr.31676. Epub 2018 Oct 9. Cancer. 2018. PMID: 30299542 Clinical Trial.
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.
Ramakrishnan S, Hu Q, Krishnan N, Wang D, Smit E, Granger V, Rak M, Attwood K, Johnson C, Morrison C, Pili R, Chatta G, Guru K, Gueron G, McNally L, Wang J, Woloszynska-Read A. Ramakrishnan S, et al. Among authors: johnson c. Cell Death Dis. 2017 Dec 14;8(12):3217. doi: 10.1038/s41419-017-0024-5. Cell Death Dis. 2017. PMID: 29242529 Free PMC article.
Vitamin D deficiency and insufficiency among patients with prostate cancer.
Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS. Trump DL, et al. Among authors: johnson cs. BJU Int. 2009 Oct;104(7):909-14. doi: 10.1111/j.1464-410X.2009.08531.x. Epub 2009 Apr 4. BJU Int. 2009. PMID: 19426195 Free PMC article.
Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.
Yao S, Haddad SA, Hu Q, Liu S, Lunetta KL, Ruiz-Narvaez EA, Hong CC, Zhu Q, Sucheston-Campbell L, Cheng TY, Bensen JT, Johnson CS, Trump DL, Haiman CA, Olshan AF, Palmer JR, Ambrosone CB. Yao S, et al. Among authors: johnson cs. Int J Cancer. 2016 May 1;138(9):2118-26. doi: 10.1002/ijc.29954. Epub 2015 Dec 28. Int J Cancer. 2016. PMID: 26650177 Free PMC article.
Vitamin D and miRNAs in cancer.
Ma Y, Trump DL, Johnson CS. Ma Y, et al. Among authors: johnson cs. Curr Gene Ther. 2014;14(4):269-75. doi: 10.2174/1566523214666140612153537. Curr Gene Ther. 2014. PMID: 25039615 Review.
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, Sucheston LE, Tang L, Roberts M, Ciupak G, Davis W, Hwang H, Johnson CS, Trump DL, McCann SE, Ademuyiwa F, Pawlish KS, Bandera EV, Ambrosone CB. Yao S, et al. Among authors: johnson cs. Breast Cancer Res. 2012 Apr 4;14(2):R58. doi: 10.1186/bcr3162. Breast Cancer Res. 2012. PMID: 22480149 Free PMC article.
Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.
Bunch BL, Ma Y, Attwood K, Amable L, Luo W, Morrison C, Guru KA, Woloszynska-Read A, Hershberger PA, Trump DL, Johnson CS. Bunch BL, et al. Among authors: johnson cs. Cancer Med. 2019 May;8(5):2449-2461. doi: 10.1002/cam4.2119. Epub 2019 Apr 10. Cancer Med. 2019. PMID: 30972950 Free PMC article.
The role of vitamin D in cancer prevention and treatment.
Krishnan AV, Trump DL, Johnson CS, Feldman D. Krishnan AV, et al. Among authors: johnson cs. Endocrinol Metab Clin North Am. 2010 Jun;39(2):401-18, table of contents. doi: 10.1016/j.ecl.2010.02.011. Endocrinol Metab Clin North Am. 2010. PMID: 20511060 Free PMC article. Review.
Vitamin D in combination cancer treatment.
Ma Y, Trump DL, Johnson CS. Ma Y, et al. Among authors: johnson cs. J Cancer. 2010 Jul 15;1:101-7. doi: 10.7150/jca.1.101. J Cancer. 2010. PMID: 20842231 Free PMC article.
519 results
Jump to page